| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4410221
[patent_doc_number] => 06228844
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Stimulating vascular growth by administration of DNA sequences encoding VEGF'
[patent_app_type] => 1
[patent_app_number] => 8/979686
[patent_app_country] => US
[patent_app_date] => 1997-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 28964
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228844.pdf
[firstpage_image] =>[orig_patent_app_number] => 979686
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/979686 | Stimulating vascular growth by administration of DNA sequences encoding VEGF | Nov 25, 1997 | Issued |
Array
(
[id] => 1391482
[patent_doc_number] => 06537523
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-25
[patent_title] => 'Diagnosis and treatment of cancer having clonal macrophage involvement'
[patent_app_type] => B1
[patent_app_number] => 08/975532
[patent_app_country] => US
[patent_app_date] => 1997-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10482
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/537/06537523.pdf
[firstpage_image] =>[orig_patent_app_number] => 08975532
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/975532 | Diagnosis and treatment of cancer having clonal macrophage involvement | Nov 19, 1997 | Issued |
Array
(
[id] => 1565977
[patent_doc_number] => 06339183
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-15
[patent_title] => 'Transgenic mammals expressing heterologous DNA in urothelium and isolation of biologically active molecules from urine'
[patent_app_type] => B1
[patent_app_number] => 08/969315
[patent_app_country] => US
[patent_app_date] => 1997-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 5458
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/339/06339183.pdf
[firstpage_image] =>[orig_patent_app_number] => 08969315
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/969315 | Transgenic mammals expressing heterologous DNA in urothelium and isolation of biologically active molecules from urine | Nov 12, 1997 | Issued |
| 08/961443 | TRANSGENIC ANIMALS THAT PRODUCE HUMAN HEMOGLOBIN | Oct 29, 1997 | Abandoned |
Array
(
[id] => 4410324
[patent_doc_number] => 06172277
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Non-transgenic rodent model of alzheimer\'s disease'
[patent_app_type] => 1
[patent_app_number] => 8/959148
[patent_app_country] => US
[patent_app_date] => 1997-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7910
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/172/06172277.pdf
[firstpage_image] =>[orig_patent_app_number] => 959148
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/959148 | Non-transgenic rodent model of alzheimer's disease | Oct 27, 1997 | Issued |
| 08/959473 | NUCLEAR TRANSFER IN ANIMALS | Oct 27, 1997 | Abandoned |
Array
(
[id] => 4295323
[patent_doc_number] => 06197754
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Suppression of tumor growth by a mini-E1A gene'
[patent_app_type] => 1
[patent_app_number] => 8/945424
[patent_app_country] => US
[patent_app_date] => 1997-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 31230
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197754.pdf
[firstpage_image] =>[orig_patent_app_number] => 945424
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/945424 | Suppression of tumor growth by a mini-E1A gene | Oct 19, 1997 | Issued |
| 90/004801 | COLLATERAL BLOOD VESSEL FORMATION IN CARDIAC MUSCLE BY INJECTING A DNA SEQUENCE ENCODING AN ANGIOGENIC PROTEIN | Oct 14, 1997 | Issued |
Array
(
[id] => 3946082
[patent_doc_number] => 05998384
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Endoscopic administration of an HSV-tk gene to treat digestive organ cancer'
[patent_app_type] => 1
[patent_app_number] => 8/949137
[patent_app_country] => US
[patent_app_date] => 1997-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4228
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998384.pdf
[firstpage_image] =>[orig_patent_app_number] => 949137
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/949137 | Endoscopic administration of an HSV-tk gene to treat digestive organ cancer | Oct 9, 1997 | Issued |
Array
(
[id] => 4361423
[patent_doc_number] => 06175057
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-16
[patent_title] => 'Transgenic mouse model of alzheimer\'s disease and cerebral amyloid angiopathy'
[patent_app_type] => 1
[patent_app_number] => 8/947295
[patent_app_country] => US
[patent_app_date] => 1997-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 14168
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/175/06175057.pdf
[firstpage_image] =>[orig_patent_app_number] => 947295
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/947295 | Transgenic mouse model of alzheimer's disease and cerebral amyloid angiopathy | Oct 7, 1997 | Issued |
Array
(
[id] => 4295586
[patent_doc_number] => 06235970
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => 'CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus'
[patent_app_type] => 1
[patent_app_number] => 8/935052
[patent_app_country] => US
[patent_app_date] => 1997-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9878
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/235/06235970.pdf
[firstpage_image] =>[orig_patent_app_number] => 935052
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/935052 | CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus | Sep 21, 1997 | Issued |
Array
(
[id] => 1520555
[patent_doc_number] => 06413769
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => '(1,3) galactosyltransferase negative porcine cells'
[patent_app_type] => B1
[patent_app_number] => 08/929940
[patent_app_country] => US
[patent_app_date] => 1997-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10444
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413769.pdf
[firstpage_image] =>[orig_patent_app_number] => 08929940
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/929940 | (1,3) galactosyltransferase negative porcine cells | Sep 14, 1997 | Issued |
Array
(
[id] => 4158296
[patent_doc_number] => 06107476
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-22
[patent_title] => 'Nucleic acid molecule encoding a protein growth factor for inhibiting prostate cancer cell growth'
[patent_app_type] => 1
[patent_app_number] => 8/927433
[patent_app_country] => US
[patent_app_date] => 1997-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 7
[patent_no_of_words] => 8113
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/107/06107476.pdf
[firstpage_image] =>[orig_patent_app_number] => 927433
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/927433 | Nucleic acid molecule encoding a protein growth factor for inhibiting prostate cancer cell growth | Sep 10, 1997 | Issued |
Array
(
[id] => 4263163
[patent_doc_number] => 06204431
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk'
[patent_app_type] => 1
[patent_app_number] => 8/925834
[patent_app_country] => US
[patent_app_date] => 1997-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 21
[patent_no_of_words] => 10392
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/204/06204431.pdf
[firstpage_image] =>[orig_patent_app_number] => 925834
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/925834 | Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk | Sep 4, 1997 | Issued |
Array
(
[id] => 4177724
[patent_doc_number] => 06159464
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints'
[patent_app_type] => 1
[patent_app_number] => 8/924376
[patent_app_country] => US
[patent_app_date] => 1997-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 62
[patent_no_of_words] => 29777
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159464.pdf
[firstpage_image] =>[orig_patent_app_number] => 924376
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/924376 | Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints | Sep 4, 1997 | Issued |
Array
(
[id] => 4311716
[patent_doc_number] => 06316419
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Induction of angiogenesis in heart muscle by a DNA sequence encoding an angiogenic protein'
[patent_app_type] => 1
[patent_app_number] => 8/909496
[patent_app_country] => US
[patent_app_date] => 1997-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5971
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316419.pdf
[firstpage_image] =>[orig_patent_app_number] => 909496
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/909496 | Induction of angiogenesis in heart muscle by a DNA sequence encoding an angiogenic protein | Aug 11, 1997 | Issued |
Array
(
[id] => 3986779
[patent_doc_number] => 05985266
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => 'Radiation enhanced therapy for tumors expressing a gene for viral thymidine kinase in the presence of a 5-halogengated pyrimidine'
[patent_app_type] => 1
[patent_app_number] => 8/903459
[patent_app_country] => US
[patent_app_date] => 1997-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8310
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/985/05985266.pdf
[firstpage_image] =>[orig_patent_app_number] => 903459
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/903459 | Radiation enhanced therapy for tumors expressing a gene for viral thymidine kinase in the presence of a 5-halogengated pyrimidine | Jul 29, 1997 | Issued |
Array
(
[id] => 3907496
[patent_doc_number] => 05898094
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-27
[patent_title] => 'Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes'
[patent_app_type] => 1
[patent_app_number] => 8/903518
[patent_app_country] => US
[patent_app_date] => 1997-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 7330
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/898/05898094.pdf
[firstpage_image] =>[orig_patent_app_number] => 903518
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/903518 | Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes | Jul 29, 1997 | Issued |
Array
(
[id] => 3896580
[patent_doc_number] => 06000772
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-14
[patent_title] => 'Tubulin promoter regulates gene expression in neurons'
[patent_app_type] => 1
[patent_app_number] => 8/900026
[patent_app_country] => US
[patent_app_date] => 1997-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 30
[patent_no_of_words] => 9148
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/000/06000772.pdf
[firstpage_image] =>[orig_patent_app_number] => 900026
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/900026 | Tubulin promoter regulates gene expression in neurons | Jul 23, 1997 | Issued |
Array
(
[id] => 1420749
[patent_doc_number] => 06503504
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-07
[patent_title] => 'Delivery of bioactive compounds to an organism'
[patent_app_type] => B1
[patent_app_number] => 08/896152
[patent_app_country] => US
[patent_app_date] => 1997-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 42
[patent_no_of_words] => 12786
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/503/06503504.pdf
[firstpage_image] =>[orig_patent_app_number] => 08896152
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/896152 | Delivery of bioactive compounds to an organism | Jul 16, 1997 | Issued |